โ† Back

Semble ๐Ÿ‡ฌ๐Ÿ‡ง

Series C

Healthcare management platform streamlining outpatient operations by integrating practice management, EHR, and intelligent workflows.

About Semble

Semble is a healthcare management platform designed to streamline operations for outpatient providers by integrating practice management systems, electronic health records, and intelligent workflows into a single connected platform. It utilizes AI-powered features and connects with over 1,200 external tools to enhance administrative efficiency and improve patient care across various specialties.

Semble is a UK-based company founded in 2016, now around 156 people. It has raised $68.3M in disclosed funding, starting with a Series A in 2021. FundFinder classes it as Health & Bio.

Founded by Christoph Lippuner (Co-founder & CEO; repeat founder; previously J.P. Morgan, Orogo; University of St.Gallen), Mikael Landau (Co-Founder and CPO; repeat founder; previously Crisil Coalition Greenwich, Goldman Sachs; Yeshiva University), David Torres Nieto (Co-Founder / CEO; previously Figure 1, IFMSA | International Federation of Medical Students' Associations; ESNECA Business School).

Company facts from Harmonic and public filings; team backgrounds from public profiles. Refreshed weekly.

Want the latest on Semble? Our research agent pulls the current description, latest round and full investor base from public sources (about a minute).

Series C ยท Jun 2026

  • Triple Point Ventures โ€” Triple Point Ventures is a UK early stage VC investing in high growth companies with top-class teams and market leading products. ยท cheques ยฃ250k โ€“ ยฃ2M

Funding history

2021Series A ยท $8.3M
Jun 2026Series CTriple Point Ventures

โ— rounds tracked in this directory ยท โ—‹ earlier rounds web-verified from public announcements. Amounts as announced; undisclosed rounds omitted.

Raising your own round? See which European funds fit โ†’